Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-21

FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) submitted by Novartis Pharmaceuticals Corporation. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOTREL (amlodipine besylate and benazepril hydrochloride)

Snippet

SUPPL AP for LOTREL (AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE)